Literature DB >> 25135633

Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation.

Paola Devoto1,2,3, Liana Fattore3,4, Silvia Antinori1, Pierluigi Saba1, Roberto Frau1,2, Walter Fratta1,3, Gian Luigi Gessa1,2,4.   

Abstract

Previous investigations indicate that the dopamine-β-hydroxylase (DBH) inhibitors disulfiram and nepicastat suppress cocaine-primed reinstatement of cocaine self-administration behaviour. Moreover, both inhibitors increase dopamine release in the rat medial prefrontal cortex (mPFC) and markedly potentiate cocaine-induced dopamine release in this region. This study was aimed to clarify if the suppressant effect of DBH inhibitors on cocaine reinstatement was mediated by the high extracellular dopamine in the rat mPFC leading to a supra-maximal stimulation of D1 receptors in the dorsal division of mPFC, an area critical for reinstatement of cocaine-seeking behaviour. In line with previous microdialysis studies in drug-naïve animals, both DBH inhibitors potentiated cocaine-induced dopamine release in the mPFC, in the same animals in which they also suppressed reinstatement of cocaine seeking. Similar to the DBH inhibitors, L-DOPA potentiated cocaine-induced dopamine release in the mPFC and suppressed cocaine-induced reinstatement of cocaine-seeking behaviour. The bilateral microinfusion of the D1 receptor antagonist SCH 23390 into the dorsal mPFC not only prevented cocaine-induced reinstatement of cocaine seeking but also reverted both disulfiram- and L-DOPA-induced suppression of reinstatement. Moreover, the bilateral microinfusion of the D1 receptor agonist chloro-APB (SKF 82958) into the dorsal mPFC markedly attenuated cocaine-induced reinstatement of cocaine seeking. These results suggest that stimulation of D1 receptors in the dorsal mPFC plays a crucial role in cocaine-induced reinstatement of cocaine seeking, whereas the suppressant effect of DBH inhibitors and L-DOPA on drug-induced reinstatement is mediated by a supra-maximal stimulation of D1 receptors leading to their inactivation.
© 2014 Society for the Study of Addiction.

Entities:  

Keywords:  Cocaine-seeking reinstatement; DBH inhibitor; L-DOPA; microdialysis; noradrenaline

Mesh:

Substances:

Year:  2014        PMID: 25135633     DOI: 10.1111/adb.12178

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  6 in total

1.  Norepinephrine regulates cocaine-primed reinstatement via α1-adrenergic receptors in the medial prefrontal cortex.

Authors:  Karl T Schmidt; Jason P Schroeder; Stephanie L Foster; Katherine Squires; Brilee M Smith; Elizabeth G Pitts; Michael P Epstein; David Weinshenker
Journal:  Neuropharmacology       Date:  2017-04-06       Impact factor: 5.250

2.  Transplantation of human retinal pigment epithelial cells in the nucleus accumbens of cocaine self-administering rats provides protection from seeking.

Authors:  Kala Venkiteswaran; Danielle N Alexander; Matthew D Puhl; Anand Rao; Amanda L Piquet; Jennifer E Nyland; Megha P Subramanian; Puja Iyer; Matthew M Boisvert; Erin Handly; Thyagarajan Subramanian; Patricia Sue Grigson
Journal:  Brain Res Bull       Date:  2015-11-10       Impact factor: 4.077

3.  Limited modulation of the abuse-related behavioral effects of d-methamphetamine by disulfiram.

Authors:  Fernando B de Moura; Stephen J Kohut; Jack Bergman
Journal:  Exp Clin Psychopharmacol       Date:  2018-07-02       Impact factor: 3.157

Review 4.  Specificity and impact of adrenergic projections to the midbrain dopamine system.

Authors:  Carlos A Mejias-Aponte
Journal:  Brain Res       Date:  2016-01-26       Impact factor: 3.252

5.  Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.

Authors:  Paola Devoto; Giovanna Flore; Pierluigi Saba; Roberto Frau; Gian L Gessa
Journal:  Brain Behav       Date:  2015-09-24       Impact factor: 2.708

6.  Treatment with dopamine β-hydroxylase (DBH) inhibitors prevents morphine use and relapse-like behavior in rats.

Authors:  Małgorzata Frankowska; Paulina Surówka; Agata Suder; Renata Pieniążek; Renata Pukło; Joanna Jastrzębska; Władysława A Daniel; Małgorzata Filip; Magdalena Zadrożny-Bujalska; Patrycja Kleczkowska
Journal:  Pharmacol Rep       Date:  2021-07-08       Impact factor: 3.024

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.